logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11752157 B1

PDFFull Text
Date of Patent:
Sep. 12, 2023

Filed:

May. 18, 2020

Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies

Applicant:

Ferring B.v., Hoofddorp, NL;

Inventor:

Joan-Carles Arce, Dragor, DK;

Assignee:

Ferring B.V., Hoofddorp, NL;

Attorneys:

Choate, Hall & Stewart LLP

Rolando Medina

Dana M. Daukss

Primary Examiner:

Christine H Matthews

Assistant Examiner:

Joshua Daryl D Lannu

Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61B 17/435 (2006.01); A61K 31/57 (2006.01); A61K 38/095 (2019.01); A61K 38/12 (2006.01); A61K 45/06 (2006.01); A61K 31/4045 (2006.01); A61K 31/565 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/57 (2013.01); A61B 17/435 (2013.01); A61K 9/0019 (2013.01); A61K 9/0034 (2013.01); A61K 31/404 (2013.01); A61K 31/4045 (2013.01); A61K 31/565 (2013.01); A61K 38/095 (2019.01); A61K 38/12 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to the use of an oxytocin receptor antagonist in females undergoing embryo transfer as part of an assisted reproductive technology. In particular, methods are provided for increasing ongoing implantation rate, increasing ongoing pregnancy rate, increasing clinical pregnancy rate, and/or increasing live birth rate in a female subject undergoing embryo transfer. Specifically, the antagonists are released in the luteal phase when the endometrium is receptive for embryo implantation and/or when the embryo has reached the blastocyst-stage.

Find Patent Forward Citations

Arce, Joan-Carles. (2023). Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies (U.S. Patent No. 11752157). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11752157

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…